Look for:

Our offer for

ABBVIE INC.


ISIN:
US00287Y1091
WKN:
00287Y109

2021/10/15 22:10:00
Price
109.33 USD
Difference 0.39% (0.42)

General attributes

ISINUS00287Y1091
SymbolABBV
ExchangeNYSE
CurrencyUSD
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)166,557 EUR
BenchmarkS&P 500

Market data

Bid (Bid size)108.00 USD (100)
Ask (Ask size)109.50 USD (100)
Open109.15 USD
High109.9616 USD
Low109.08 USD
Close (prev. day)108.91 USD
VWAP109.328503 USD
Volume (pcs)4,634,513
Trading volume506,694,986.72
Number of trades42,765
Last size-

Futures and Options

Related Futures14
Related Options-

PDF Downloads

Company report: ABBVIE INC.PDF Download

Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Recent research



2021/10/15 22:10:00
Price
109.33 USD
Difference 0.39% (0.42)

General attributes

ISINUS00287Y1091
SymbolABBV
ExchangeNYSE
CurrencyUSD
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)166,557 EUR
BenchmarkS&P 500

Market data

Bid (Bid size)108.00 USD (100)
Ask (Ask size)109.50 USD (100)
Open109.15 USD
High109.9616 USD
Low109.08 USD
Close (prev. day)108.91 USD
VWAP109.328503 USD
Volume (pcs)4,634,513
Trading volume506,694,986.72
Number of trades42,765
Last size-

Performance and Risk

6m1Y3Y
Perf (%)+2.28%+28.28%+22.59%
Perf (abs.)+2.44+24.10+20.15
Beta0.560.670.76
Volatility18.4122.9029.98
Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Price data

Ø price 5 days | Ø volume 5 days (pcs.)109.14 USD (5,661,445)
Ø price 30 days | Ø volume 30 days (pcs.)108.43 USD (7,242,451)
Ø price 100 days | Ø volume 100 days (pcs.)113.61 USD (6,875,494)
Ø price 250 days | Ø volume 250 days (pcs.)108.64 USD (7,274,039)
YTD High | date121.53 USD (2021/09/01)
YTD Low | date101.81 USD (2021/01/29)
52 Weeks High | date121.53 USD (2021/09/01)
52 Weeks Low | date79.11 USD (2020/10/29)

All listings for ABBVIE INC.

Exchange  DateTimePriceTrading volume (mio.)Number of trades
Xetra2021/10/1517:3594.00 EUR0.2260
Vienna Stock Exchange2021/10/1517:3294.12 EUR0.003
Tradegate2021/10/1522:2694.25 EUR0.4999
Stuttgart2021/10/1519:5693.98 EUR0.019
NYSE2021/10/1522:10109.33 USD506.6942,765
Munich2021/10/1508:0393.91 EUR0.002
London Stock Exchange European Trade Reporting2021/10/1517:30109.39 USD0.044
Frankfurt2021/10/1514:2994.13 EUR0.046
Duesseldorf2021/10/1519:3193.87 EUR0.0011
Berlin2021/10/1519:3594.20 EUR0.0015

Company Logo

https://gateway.mdgms.com/extern/logo_image.html?ID_LOGO=138490&ID_TYPE_IMAGE_LOGO=2

Contact Details

ABBVIE, INC.
- -
1 North Waukegan Road - 60064-6400 North Chicago
Telefon: 1-847-932-7900
Fax: -
E-mail: -

PDF Downloads

Company report: ABBVIE INC.PDF Download

Company Profile

AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.

Members of Management Board

Robert AlpernMember of Board of Directors
Brett HartMember of Board of Directors
Edward LiddyMember of Board of Directors
Edward RappMember of Board of Directors
Frederick WaddellMember of Board of Directors
Glenn TiltonMember of Board of Directors
Melody MeyerMember of Board of Directors
Rebecca RobertsMember of Board of Directors
Roxanne AustinMember of Board of Directors
Thomas FreymanMember of Board of Directors
William BurnsideMember of Board of Directors
Richard A. GonzalezChairman of Managing Board
Azita Saleki-GerhardtMember of Executive Committee
Carrie StromMember of Executive Committee
Henry O. GosebruchMember of Executive Committee
Jeffrey R. StewartMember of Executive Committee
Laura J. SchumacherMember of Executive Committee
Michael E. SeverinoMember of Executive Committee
Rae L. LivingstonMember of Executive Committee
Robert A. MichaelMember of Executive Committee
Timothy J. RichmondMember of Executive Committee






Decline
Accept

We use cookies and web analysis software to give you the best possible experience on our website. If you consent, these tools will be used. For more details please read our Data protection policy.

INFORMATION FOR PRIVATE CLIENTS / CONSUMERS

Any information, material and services regarding financial instruments and securities provided by Česká spořitelna/Erste Group/ or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites“) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions.

By agreeing to this hereto, the visitor entering this Websites confirms that has read, understood and accepted this Information and the Disclaimer